openPR Logo
Press release

United States BCG Vaccine Market Analysis | Key Manufacturers, Demand Rises with WHO TB Elimination Goals & Healthcare Investments | China National Biotech Group, Serum Institute of India Pvt. Ltd, InterVax Ltd, GREENSIGNAL BIO PHARMA LIMITED (GSBPL), and

11-05-2025 10:39 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

BCG Vaccine Market

BCG Vaccine Market

DataM Intelligence unveils its latest report on the "BCG Vaccine Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

According to the Global TB Report, the majority of TB cases occurred in South-East Asia (43%), Africa (25%), and the Western Pacific (18%). The 30 high-burden countries accounted for 86% of global cases, with India, China, Indonesia, the Philippines, Pakistan, Nigeria, Bangladesh, and South Africa making up two-thirds of the total. This high prevalence in emerging economies is expected to drive demand for BCG vaccines during the forecast period.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/bcg-vaccine-market?kb

Latest M&A

BCG-related M&A activity is moderate but expected to increase with biotech companies pursuing recombinant BCG vaccines and novel TB vaccine candidates amid a global push for tuberculosis eradication.

Big pharma and vaccine manufacturers are strengthening pipelines through licensing and acquisitions, focusing on enhanced efficacy, recombinant technologies, and better production methods.

List of Top Key Player:

Sanofi Pasteur, Merck & Co, Japan BCG Laboratory, China National Biotech Group, Serum Institute of India Pvt. Ltd, InterVax Ltd, GREENSIGNAL BIO PHARMA LIMITED (GSBPL), and STATENS SERUM INSTITUTE.

Latest News

The global BCG vaccine market was valued around $159 million in 2023 and projected to reach $243 million by 2032 with a CAGR of about 6.27%, driven by rising TB incidence and immunization efforts.

Recombinant BCG vaccines are gaining traction for improved safety and efficacy profiles; ongoing research expands their use in bladder cancer immunotherapy and immune modulation.

WHO recommends BCG vaccination at birth in endemic regions; India launched extensive campaigns including BCG revaccination strategies.

The U.S. faced a BCG vaccine shortage which ended in early 2025 with introduction of recombinant BCG by ImmunityBio in partnership with Serum Institute of India.

Forecast Projection:

The Global BCG Vaccine Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The BCG Vaccine Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=bcg-vaccine-market?kb

Key Segmentation:

By Product: (Immune BCG, Therapy BCG)

By Demographics: (Pediatrics (0-18 Years), Adults (19-35 Years)

By Application: (Hospitals, Clinics),

Global Growth Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Latest FDA Approvals

FDA approved Merck's TICE® BCG vaccine for bladder cancer and tuberculosis prevention; recombinant BCG (rBCG) received expanded access authorization to address shortages.

FDA approved gemcitabine intravesical system for BCG-unresponsive non-muscle invasive bladder cancer in September 2025.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/bcg-vaccine-market?kb

Reimbursement

Reimbursement frameworks vary globally; many countries provide full or partial reimbursement for BCG vaccines under public health immunization programs.

Belgium extended full Kaftrio reimbursement (CFTR modulator, related to CF and indirectly linked to immunocompromised states) to young children, indicative of pediatric drug reimbursement trends.

Neuro-implant reimbursement schemes include BCG-related therapies under some health systems, indicating growing acknowledgment of therapeutic value.

Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/bcg-vaccine-market?kb

Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States BCG Vaccine Market Analysis | Key Manufacturers, Demand Rises with WHO TB Elimination Goals & Healthcare Investments | China National Biotech Group, Serum Institute of India Pvt. Ltd, InterVax Ltd, GREENSIGNAL BIO PHARMA LIMITED (GSBPL), and here

News-ID: 4254845 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

United States Smart Transportation Industry Sector Poised for Rapid Growth By 2032 | Top Companies - AGT International, AVEVA Group plc, ERTICO-ITS, Orange Business Services, Cisco Systems Inc.
United States Smart Transportation Industry Sector Poised for Rapid Growth By 20 …
DataM Intelligence unveils its latest report on the "Smart Transportation Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming
United States Dietary Fibers Market to Grow at 8.5% CAGR, Driven by Rising Health Consciousness and Functional Food Demand | DataM Intelligence
United States Dietary Fibers Market to Grow at 8.5% CAGR, Driven by Rising Healt …
The global dietary fibers market reached US$ 6.4 billion in 2022 and is expected to reach US$ 12.2 billion by 2031, growing at a CAGR of 8.5% during the forecast period 2024-2031, according to DataM Intelligence. United States: Recent Industry Developments ✅ In October 2025, Cargill Incorporated launched a new soluble fiber blend with 40% improved gut health benefits for functional foods. ✅ In September 2025, The U.S. Food and Drug Administration
Charcoal Market Outlook 2024-2031: Growth Driven by Activated Charcoal Demand and Sustainable Fuel Applications | Top Players Include Kingsford, Duraflame, and Timber Charcoal Co.
Charcoal Market Outlook 2024-2031: Growth Driven by Activated Charcoal Demand an …
The global charcoal market reached US$ 6.8 billion in 2023 and is expected to reach US$ 8.7 billion by 2031, growing at a CAGR of 3.10% during the forecast period (2024-2031). Market growth is primarily driven by rising demand from the cement production and food processing industries, along with the growing popularity of barbecue cooking and eco-friendly fuel alternatives. Charcoal's versatility in industrial and household applications continues to strengthen its
United States Brain Implants Market | Industry Developments, Future Growth, Share & Industry Insights | LivaNova PLC, NeuroPace Inc, Sapiens Neuro, Neuralink, Nexstim
United States Brain Implants Market | Industry Developments, Future Growth, Shar …
DataM Intelligence unveils its latest report on the "Brain Implants Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming

All 5 Releases


More Releases for BCG

BCG Vaccine Market May See Big Move | Japan BCG Laboratory, GSK, GreenSignal Bio …
HTF MI just released the Global BCG Vaccine Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Major Giants in BCG Vaccine Market are: Merck & Co., Sanofi, Serum
Global BCG Tuberculosis Vaccine Market An Overview | Japan BCG Laboratory, China …
Astute Analytica, a leading provider of market research and analysis, released its highly anticipated Market Analysis Report on the Global BCG Tuberculosis Vaccine Market. This comprehensive report aims to equip businesses with invaluable insights and data, enabling them to make informed decisions and stay one step ahead of the competition. Access the Comprehensive PDF Market Research Analysis Report Here:​​​​​​​ https://www.astuteanalytica.com/request-sample/bcg-tuberculosis-vaccine-market The Global BCG Tuberculosis Vaccine Market was valued at US$ 63.58
Increasing Demand For Therapeutic BCG Vaccines Drives Market Growth - Merck & Co …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Therapeutic BCG Vaccines Market Size, Growth Rate, And Forecast The global therapeutic BCG vaccines market size is expected to grow from $50.73 billion in 2022 to $53.18 billion in 2023 at a compound annual growth rate (CAGR) of 4.82%. The Russia-Ukraine war disrupted the chances of global economic
BCG Vaccine Market Swot Analysis by key players Merck, Sanofi Pasteur, Japan BCG …
BCG Vaccine Market Status and Trend Analysis 2017-2026 (COVID-19 Version) is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the BCG Vaccine Market. Some of the key players profiled in the study are Merck, Sanofi Pasteur,
BCG Vaccine Market: Development Factors and Investment Analysis by Leading Manuf …
LOS ANGELES, United States 2020: This BCG Vaccine market report work with respect to opportunities, challenges, drivers, market structures, and competitive landscape for the clients. The report is a complete overview of the market, covering various aspects including product definition, market segmentation based on various parameters, and the prevailing vendor landscape. The report is helpful to present you better solutions in terms of product trends, future products, marketing strategy, future
BCG Vaccine Booming Segments; Investors Seeking Growth | Sanofi Pasteur, Japan B …
Latest Research Study on Global BCG VaccineMarket published by AMA, offers a detailed overview of the factors influencing the global business scope.Global BCG Vaccine Market research report shows the latest market insights with upcoming trends and breakdown of the products and services.The report provides key statistics on the market status, size, share, growth factors, Challenges and Current Scenario Analysis of the Global BCG Vaccine.This Report also covers the emerging player's